Consortium-Based Genetic Studies of Kawasaki Disease in Korea: Korean Kawasaki Disease Genetics Consortium.
10.4070/kcj.2015.45.6.443
- Author:
Jong Keuk LEE
1
;
Young Mi HONG
;
Gi Young JANG
;
Sin Weon YUN
;
Jeong Jin YU
;
Kyung Lim YOON
;
Kyung Yil LEE
;
Hong Rang KIL
Author Information
1. Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul, Korea. cookie_jklee@hotmail.com
- Publication Type:Review
- Keywords:
Mucocutaneous lymph node syndrome;
Genome-wide association study;
Polymorphism, single nucleotide
- MeSH:
Aneurysm;
C-Reactive Protein;
Coronary Vessels;
Data Collection;
DNA;
Exome;
Genetics*;
Genome-Wide Association Study;
Humans;
Immunoglobulins;
Immunoglobulins, Intravenous;
Korea*;
Mucocutaneous Lymph Node Syndrome*;
Plasma;
Polymorphism, Single Nucleotide;
Promoter Regions, Genetic;
Risk Factors;
Serum Albumin
- From:Korean Circulation Journal
2015;45(6):443-448
- CountryRepublic of Korea
- Language:English
-
Abstract:
In order to perform large-scale genetic studies of Kawasaki disease (KD) in Korea, the Korean Kawasaki Disease Genetics Consortium (KKDGC) was formed in 2008 with 10 hospitals. Since the establishment of KKDGC, there has been a collection of clinical data from a total of 1198 patients, and approximately 5 mL of blood samples per patient (for genomic deoxyribonucleic acid and plasma isolation), using a standard clinical data collection form and a nation-wide networking system for blood sample pick-up. In the clinical risk factor analysis using the collected clinical data of 478 KD patients, it was found that incomplete KD type, intravenous immunoglobulin (IVIG) non-responsiveness, and long febrile days are major risk factors for coronary artery lesions development, whereas low serum albumin concentration is an independent risk factor for IVIG non-responsiveness. In addition, we identified a KD susceptibility locus at 1p31, a coronary artery aneurysm locus (KCNN2 gene), and the causal variant in the C-reactive protein (CRP) promoter region, as determining the increased CRP levels in KD patients, by means of genome-wide association studies. Currently, this consortium is continually collecting more clinical data and genomic samples to identify the clinical and genetic risk factors via a single nucleotide polymorphism chip and exome sequencing, as well as collaborating with several international KD genetics teams. The consortium-based approach for genetic studies of KD in Korea will be a very effective way to understand the unknown etiology and causal mechanism of KD, which may be affected by multiple genes and environmental factors.
